BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35993523)

  • 1. Effects of
    Furtado Macruz C; Lima SMRR
    J Obstet Gynaecol; 2022 Oct; 42(7):3236-3240. PubMed ID: 35993523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
    Rostock M; Fischer J; Mumm A; Stammwitz U; Saller R; Bartsch HH
    Gynecol Endocrinol; 2011 Oct; 27(10):844-8. PubMed ID: 21231853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-risk profile of black cohosh (isopropanolic
    Ruan X; Mueck AO; Beer AM; Naser B; Pickartz S
    Climacteric; 2019 Aug; 22(4):339-347. PubMed ID: 30626212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints--an observational study.
    Drewe J; Zimmermann C; Zahner C
    Phytomedicine; 2013 Jun; 20(8-9):659-66. PubMed ID: 23537746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life and Climacteric Symptoms in Postmenopausal Women Receiving Hormone Therapy for Breast Cancer.
    Macruz CF; Lima SMRR; Postigo S; Martins MM; Lucarelli AP; de Oliveira VM
    J Obstet Gynaecol Can; 2020 Oct; 42(10):1243-1247. PubMed ID: 32487509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.
    Walji R; Boon H; Guns E; Oneschuk D; Younus J
    Support Care Cancer; 2007 Aug; 15(8):913-21. PubMed ID: 17602247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review.
    Laakmann E; Grajecki D; Doege K; zu Eulenburg C; Buhling KJ
    Gynecol Endocrinol; 2012 Sep; 28(9):703-9. PubMed ID: 22385322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
    Kanadys WM; Leszczyńska-Gorzelak B; Oleszczuk J
    Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic and clinical studies using Cimicifuga racemosa in climacteric complaints].
    Winterhoff H; Butterweck V; Jarry H; Wuttke W
    Wien Med Wochenschr; 2002; 152(15-16):360-3. PubMed ID: 12244879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black cohosh: an alternative therapy for menopause?
    Mahady GB; Fabricant D; Chadwick LR; Dietz B
    Nutr Clin Care; 2002; 5(6):283-9. PubMed ID: 12557811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Cimicifuga foetida extract on menopausal syndrome in Chinese women.
    Zheng TP; Sun AJ; Xue W; Wang YP; Jiang Y; Zhang Y; Lang JH
    Chin Med J (Engl); 2013; 126(11):2034-8. PubMed ID: 23769553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.
    Nappi RE; Malavasi B; Brundu B; Facchinetti F
    Gynecol Endocrinol; 2005 Jan; 20(1):30-5. PubMed ID: 15969244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial.
    Sammartino A; Tommaselli GA; Gargano V; di Carlo C; Attianese W; Nappi C
    Gynecol Endocrinol; 2006 Nov; 22(11):646-50. PubMed ID: 17145651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.
    Hernández Muñoz G; Pluchino S
    Maturitas; 2003 Mar; 44 Suppl 1():S59-65. PubMed ID: 12609560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7.
    Gaube F; Wolfl S; Pusch L; Kroll TC; Hamburger M
    BMC Pharmacol; 2007 Sep; 7():11. PubMed ID: 17880733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 60 years of Cimicifuga racemosa medicinal products : Clinical research milestones, current study findings and current development.
    Henneicke-von Zepelin HH
    Wien Med Wochenschr; 2017 May; 167(7-8):147-159. PubMed ID: 28155126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black cohosh: efficacy, safety, and use in clinical and preclinical applications.
    McKenna DJ; Jones K; Humphrey S; Hughes K
    Altern Ther Health Med; 2001; 7(3):93-100. PubMed ID: 11347288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treat more than heat-New therapeutic implications of Cimicifuga racemosa through AMPK-dependent metabolic effects.
    Drewe J; Boonen G; Culmsee C
    Phytomedicine; 2022 Jun; 100():154060. PubMed ID: 35338990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause.
    Amsterdam JD; Yao Y; Mao JJ; Soeller I; Rockwell K; Shults J
    J Clin Psychopharmacol; 2009 Oct; 29(5):478-83. PubMed ID: 19745648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms.
    Mahady GB
    Treat Endocrinol; 2005; 4(3):177-84. PubMed ID: 15898823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.